DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD)
DMC’s technology platform addresses the key barriers that have plagued the biotech industry for decades
07-Dec-2021 -
DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD) with investment from Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy Ventures, SCG, Boulder Ventures, Solvay Ventures and Michelin.
DMC is commercial with its ...
animal nutrition
financing
Series B financing